Skip to main content
Watch Insiders
BRVE filings

Corporate insider profile

Benjamin A Horowitz Filing Activity

Latest reported as Corporate insider of Braveheart Bio, Inc. (BRVE).

Purchase filings
2
Reported companies
3
Net open-market value
$13,049,995
Latest transaction
Aug 7, 2026

Affiliated corporations

Reported company relationships

BRVELatest reported

Braveheart Bio, Inc.

Corporate insider

SCTXPrior filing

Scribe Therapeutics, Inc.

Corporate insider

NAUTPrior filing

Nautilus Biotechnology, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 7, 2026Braveheart Bio, Inc. (BRVE)Corporate insiderOpen Market Purchase1,100,000$18.00$19,800,000
Jul 27, 2026Scribe Therapeutics, Inc. (SCTX)Corporate insiderOpen Market Purchase333,333$15.00$4,999,995
Jun 2, 2026Nautilus Biotechnology, Inc. (NAUT)Corporate insiderSale5,000,000$2.35$11,750,000